We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata
Blog

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.

Read More

Single Cell Analysis – Advantages, Challenges, and Applications
Blog

We recently spoke with Dr Marian Rehak, VP of Research and Development at Sphere Fluidics, to learn more about the importance of single cell analysis. Marian touches on some of the common challenges encountered and highlights some of the key applications.

Read More

NRGene are Taking Agricultural Research to the MAX
Blog

NRGene recently announced the launch of DeNovoMAX, an enhanced version of its flagship product DeNovoMAGIC, for whole genome assembly. As part of the DeNovo assembly product suite, DeNovoMAX aims to take agricultural research further by empowering breeding and maximizing agricultural yield. We spoke with Gal Ramot, Marketing Director at NRGene Ltd to learn about the applications of DeNovoMAX and how it has been built to crack the most "complex of genomes".

Read More

Wellness and Illness From a Precision Quantification Perspective
Blog

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.

Read More

DNA and RNA: Why It’s All About Integrity
Blog

In this interview, we spoke with Knut Wintergerst, PhD, General Manager of Biomolecular Systems and Solutions (BSS) and Diagnostics and Genomics Group (DGG) at Agilent to learn more about why DNA and RNA sample integrity is important to scientists and how it can be maintained and analyzed.

Read More

Colorectal Cancer Blood Test Driven by Immuno-transcriptomics
Blog

By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.

Read More

DNA Methylation Analysis for Early Detection of Various Cancers
Blog

We recently spoke to Richard Brand, CFO and Dhruvajyoti Roy, Director of Technology from the Laboratory for Advanced Medicine (LAM) to learn more about how LAM is developing methylation-based tests for the early detection and intervention of cancer.

Read More

Why Should Antibodies Be Manufactured Recombinantly?
Blog

Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.

Read More

A Microfluidic Approach to Gene Delivery in GMCT
Blog

The development of GMCTs has been halted by issues surrounding the most critical step in their creation, the introduction of new genetic material. Recently, Indee Labs announced the publication of a study illustrating the efficacy of it's GMCT development and manufacturing technology. We spoke with Indee Labs' CEO Ryan Pawell to learn more about the technology and its applications.

Read More

Single-cell DNA Analysis: Driving Dynamic Changes in the Treatment of Cancer
Blog

We recently spoke to Charlie Silver, CEO and Co-Founder of Mission Bio, to learn more about how they are helping researchers profile mutational heterogeneity at the single-cell level.

Read More